Successful Clinical Avoidance of Colorectal Anastomotic Leakage through Local Decontamination

Gerhard Ernst Steyer,Markus Puchinger,Johann Pfeifer

DOI: https://doi.org/10.3390/antibiotics13010079

2024-01-16

Antibiotics

Abstract:Aim: An anastomotic leak is an unpredictable postoperative complication during recovery from colorectal surgery that may require a re-operation. Potentially pathogenic bacteria like Pseudomonas (and Enterococcus) contribute to the pathogenesis of an anastomotic leak through their capacity to degrade collagen and to activate tissue matrix metalloprotease-9 in host intestinal tissues. The microbiome, therefore, is the key to preventing an anastomotic leak after colorectal surgery. The aim of this trial was to investigate whether perioperative selective decontamination with a new mixture of locally acting antibiotics specially designed against Pseudomonas aeruginosa and Enterococcus faecalis can reduce or even stop early symptomatic leakage. Method: All hospitalized patients in our University Clinic undergoing colorectal surgery with a left-sided anastomosis were included as two groups; patients in the intervention group received polymyxin B, gentamicin and vancomycin every six hours for five postoperative days and those in the control group did not receive such an intervention. An anastomotic leak was defined as a clinically obvious defect of the intestinal wall integrity at the colorectal anastomosis site (including suture) that leads to a communication between the intra- and extraluminal compartments, requiring a re-do surgery within seven postoperative days. Results: Between February 2017 and May 2023, a total of 301 patients (median age of 63 years) were analyzed. An anastomotic leak was observed in 11 patients in the control group (n = 152), but in no patients in the intervention group (n = 149); this difference was highly significant. Conclusion: The antibiotic mixture (with polymyxin B, gentamicin and vancomycin) used for local decontamination in our study stopped the occurrence of anastomotic leaks completely. According to the definition of anastomotic leak, no further surgery was required after local perioperative decontamination.

pharmacology & pharmacy,infectious diseases

What problem does this paper attempt to address?

The paper aims to address the issue of anastomotic leak (AL) following colorectal surgery. AL is an unpredictable postoperative complication that may necessitate reoperation and is associated with high mortality and morbidity. Studies have found that potential pathogens such as Pseudomonas aeruginosa and Enterococcus faecalis are involved in the pathogenesis of AL by degrading collagen and activating matrix metalloproteinase-9 (MMP9) in the host intestinal tissue. Therefore, the microbiome is considered a key factor in preventing AL after colorectal surgery.

The primary objective of this trial is to investigate whether perioperative local selective decontamination can reduce or prevent the occurrence of early symptomatic AL through a newly designed antibiotic mixture specifically targeting Pseudomonas aeruginosa and Enterococcus faecalis. Specifically, patients in the intervention group received polymyxin B, gentamicin, and vancomycin every six hours for five days postoperatively, while the control group did not receive this intervention. The study results showed that no AL was observed in the intervention group, whereas 11 patients in the control group developed AL, a significant difference. This indicates that local decontamination using this antibiotic mixture can completely prevent the occurrence of AL and obviate the need for further surgical intervention.